Clair Health raises $11.6M for hormone-tracking wearable tech
Clair Health raised $11.6M to build a noninvasive wearable and app for women’s hormonal health, adding another signal that healthtech is moving toward more personalised, continuous data.
Women’s health has historically been under-researched, underfunded and under-designed. Clair Health’s new round points to a more personalised version of healthtech built around continuous signals, not occasional check-ups.
What happened
Clair Health raised $11.6M for a noninvasive wearable and app focused on women’s hormonal health.
The company is targeting areas such as cycle irregularities, perimenopause and related health markers. The round was led by Khosla Ventures, with participation from a16z speedrun and other investors.
Why it matters
Hormonal health affects mood, energy, fertility, sleep, metabolism and long-term wellbeing, but it is often tracked through fragmented symptoms or one-off lab tests.
A wearable-first approach could make this category more continuous and data-driven. Instead of waiting for a problem to become obvious, users may be able to see patterns earlier and have better conversations with clinicians.
The bigger picture
The bigger healthtech trend is clear: consumer health is becoming more specialised. General wellness apps are giving way to products built for specific user groups, specific biological signals and more actionable data.
Clair Health sits at the intersection of women’s health, wearables and personalised monitoring — a category that still has a lot of room for serious, thoughtful product design.